Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subramanian Yegneswaran

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|August 12, 2015
Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase ComplexSubramanian Yegneswaran, Yajnavalka Banerjee, José A Fernández, et al.
The Journal of Biological Chemistry|June 8, 2007
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage siteAndrew J Gale, Subramanian Yegneswaran, Xiao Xu, et al.
Transfusion|January 16, 2026
Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complexFlorian Tupin, Clarisse Mouriaux, Michelle Gatmaitan, et al.
The Journal of Biological Chemistry|July 25, 2007
Factor Va residues 311-325 represent an activated protein C binding regionSubramanian Yegneswaran, Yumi Kojima, Phuong M Nguyen, et al.
Thrombosis and Haemostasis|October 12, 2012
Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin effluxAnnette von Drygalski, Christian Furlan-Freguia, Laurent O Mosnier, et al.
Transfusion|July 25, 2025
Assessing hepatitis B virus infectivity in blood components following pathogen reduction using a human hepatocyte modelBryan J Visser, Santanu Biswas, Rana Eltahan, et al.
Blood|July 16, 2015
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics dataHiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, et al.
Transfusion|November 14, 2025
Effects of an amustaline (S-303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole bloodM Reza Khoshi, Ayantu Jinfessa, Anais Pongerard, et al.
Transfusion|July 9, 2022
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storageJose A Cancelas, Jamie R Genthe, Moritz Stolla, et al.
Nature Communications|June 14, 2020
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophiliaXiao-Yan Zhao, Andreas Wilmen, Dongli Wang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|August 12, 2015
Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase ComplexSubramanian Yegneswaran, Yajnavalka Banerjee, José A Fernández, et al.
The Journal of Biological Chemistry|June 8, 2007
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage siteAndrew J Gale, Subramanian Yegneswaran, Xiao Xu, et al.
Transfusion|January 16, 2026
Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complexFlorian Tupin, Clarisse Mouriaux, Michelle Gatmaitan, et al.
The Journal of Biological Chemistry|July 25, 2007
Factor Va residues 311-325 represent an activated protein C binding regionSubramanian Yegneswaran, Yumi Kojima, Phuong M Nguyen, et al.
Thrombosis and Haemostasis|October 12, 2012
Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin effluxAnnette von Drygalski, Christian Furlan-Freguia, Laurent O Mosnier, et al.
Transfusion|July 25, 2025
Assessing hepatitis B virus infectivity in blood components following pathogen reduction using a human hepatocyte modelBryan J Visser, Santanu Biswas, Rana Eltahan, et al.
Blood|July 16, 2015
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics dataHiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, et al.
Transfusion|November 14, 2025
Effects of an amustaline (S-303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole bloodM Reza Khoshi, Ayantu Jinfessa, Anais Pongerard, et al.
Transfusion|July 9, 2022
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storageJose A Cancelas, Jamie R Genthe, Moritz Stolla, et al.
Nature Communications|June 14, 2020
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophiliaXiao-Yan Zhao, Andreas Wilmen, Dongli Wang, et al.
Pageof 2